Maker Lucid News Today

ImmunityBio said the QUILT 3.055 trial shows median overall survival almost double that of standard of care chemotherapy in 2nd- and 3rd-line non-small cell lung cancer (NSCLC) patients whose cancer did not respond to checkpoint inhibitors with or without chemotherapy.

SoFi is set to report its first-quarter financial results before the market open on Monday, April 29 and will host a conference call at 8:00 a.m. ET the same day. According to estimates from Benzinga Pro, analysts expect the company to report earnings of 1 cent per share and quarterly revenue of $555.997 million.

ReAlpha Tech shares are trading higher Thursday on continued upward momentum. The stock gained 93% Wednesday after the company announced the launch of its generative AI-powered tool for homebuyers, Claire.

B. Riley Financial shares are trading higher Wednesday after the company announced the results of an independent investigation showed the company and its executives had no involvement with, or knowledge of, any of the alleged misconduct concerning Brian Kahn or any of his affiliates.

Last week, AMD announced its new AMD Ryzen PRO 8040 Series with x86 processors and the AMD Ryzen PRO 8000 Series desktop processor, the first AI-enabled desktop processor for business users constructed with the advanced 4-nanometer technology.

Mattel reported quarterly losses of 5 cents per share which beat the analyst consensus estimate of losses of 12 cents per share. Quarterly sales came in at $810 million, missing the analyst consensus estimate of $831.8 million by 2.62% and representing a 0.56% decrease in sales year-over-year.

BranchOut Foods shares are trading higher Wednesday after the company announced it has expanded its existing relationship with the nation's largest retailer, which brings the total annualized value of commitments from the retailer to over $8 million.

Palantir is set to report its first-quarter financial results on May 6 after the market close. According to estimates from Benzinga Pro, analysts expect the company to report earnings of 8 cents per share and quarterly revenue of $625.33 million.

Palisade Bio entered into a collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative colitis (UC) therapy and provides the company access to advanced bioinformatics tools vital for understanding complex disease pathways and predicting responses to PDE4 inhibitors.

Cyngn shares are trading higher Tuesday after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere's operation in Dubuque, Iowa.